Which fields of science does Avalon Pharma (United States) work in?
In 2022-now, 38% of research at Avalon Pharma (United States) is in Health Sciences, 27% in Social Sciences. Its largest fields are Medicine (34%), Social Sciences (15%), Economics, Econometrics and Finance (7%). It does 1.5× the world's share of Health Sciences.
Life Sciences11%Physical Sciences24%Health Sciences38%Social Sciences27%
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
more than its size predictsabout as predictedless
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.0×. Every wedge is a field page.
All 25 fields, with their numbers
Pharmacology, Toxicology and Pharmaceutics5.01×1 works
Earth and Planetary Sciences3.78×4 works
Economics, Econometrics and Finance3.40×5 works
Dentistry3.16×1 works
Veterinary1.79×0 works
Medicine1.76×23 works
Physics and Astronomy1.70×3 works
Immunology and Microbiology1.61×1 works
Psychology1.31×3 works
Environmental Science1.28×4 works
Nursing1.24×0 works
Social Sciences1.16×10 works
Biochemistry, Genetics and Molecular Biology0.68×2 works
What are the most cited papers from Avalon Pharma (United States)?
The most cited paper from Avalon Pharma (United States) is "Genome sequence of the Brown Norway rat yields insights into mammalian evolution" (Richard A. Gibbs et al., 2004), with 2,224 citations. Next come "The Sorcerer II Global Ocean Sampling Expedition: Northwest Atlantic through Eastern Tropical Pacific" (2,118) and "Spheroid-based drug screen: considerations and practical approach" (1,764).
Which keywords describe research at Avalon Pharma (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Treatment, Substance Use Disorders, Mortality Risk, Property Rights, Chronic Pain Management, Opioid Prescribing and Neurobiology.
▲ more of its work than of the world's◆ about the world's share▼ less than the world's
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
Epidemiology6▲ 2.1×33 topics
Treatment3▲ 4.1×13 topics
Climate Change3▲ 1.52×13 topics
Machine Learning3◆ 1.13×9 topics
Quality of Life2▲ 2.5×8 topics
Substance Use Disorders2▲ 44×2 topics
Mortality Risk2▲ 13×2 topics
Property Rights2▲ 45×3 topics
Chronic Pain Management2▲ 84×1 topic
Opioid Prescribing2▲ 84×1 topic
Neurobiology2▲ 10×2 topics
Conservation2▲ 5.7×3 topics
Population Dynamics2▲ 8.7×4 topics
Risk Factors2▲ 2.0×7 topics
Depression1▲ 2.3×6 topics
Regulation1▲ 3.9×3 topics
Anxiety1▲ 4.1×5 topics
Genetics1▲ 2.6×4 topics
Precision Medicine1▲ 3.7×3 topics
Health Equity1▲ 5.8×2 topics
Meta-Analysis1▲ 2.9×4 topics
Neurobiological Correlates1▲ 17×2 topics
Plate Tectonics1▲ 12×2 topics
Prevalence1▲ 4.2×2 topics
Digital Learning1▲ 3.2×2 topics
Pharmaceutical Industry1▲ 46×2 topics
Phylogeny1▲ 9.9×3 topics
Social Responsibility1▲ 6.7×2 topics
Tectonics1▲ 13×3 topics
Clinical Decision Support1▲ 9.3×1 topic
Contracts1▲ 89×1 topic
Cost-effectiveness Analysis1▲ 19×1 topic
Emotion Regulation1▲ 4.6×2 topics
Enforcement1▲ 53×1 topic
Ethical Challenges1▲ 6.8×1 topic
Ethical Considerations1▲ 4.2×2 topics
Health Utility Measures1▲ 19×1 topic
Infectious Diseases1▲ 4.5×5 topics
Psilocybin1▲ 90×1 topic
Psychedelics1▲ 90×1 topic
Which research topics does Avalon Pharma (United States) publish most on?
Against the world's own shares: the tick on each track. Both are shares of its output, so they
sit on one scale and can be read against each other as well as against the world.
47%53%
openly available47.0%not open53.0%
World: 40% of research is openly available.
26%74%
with international co-authors25.5%domestic only74.5%
World: 18% is written across borders.
How has Avalon Pharma (United States)'s research output changed?
Output in 2022-2025 was 73% higher than in 2018-2021.
grewheldshrank
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Avalon Pharma (United States) as a percentage of every work published that year, 0.00016% in 2024.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Avalon Pharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.